1. Inicio
  2. Acciones
  3. Reino Unido
  4. London Stock Exchange
  5. GSK plc
  6. Noticias
  7. Otros idiomas
    GSK   GB0009252882

GSK PLC

(GSK)
  Reporte
Diferido London Stock Exchange  -  17:36 28/06/2022
1771.60 GBX   +0.42%
12:18GlaxoSmithKline solicita la ampliación del uso de la vacuna Shingrix contra el herpes zóster en Japón
MT
08:47GSK busca la aprobación regulatoria japonesa para la vacuna contra el herpes zóster en adultos mayores de 18 años
MT
08:00GSK plc anuncia la presentación de una solicitud reglamentaria al Ministerio de Salud, Trabajo y Bienestar de Japón (MHLW ) para Shingrix
CI
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sectorEstrategias MarketScreener
Noticias en otros idiomas sobre GSK PLC
12:28GSK : sollicite les autorités japonaises pour Shingrix
12:18GlaxoSmithKline Files for Expanded Use of Shingrix Shingles Vaccine in Japan
09:55Japan's Ministry of Health, Labour and Welfare accepts Shingrix regulatory submission t..
08:47GSK Seeks Japanese Regulatory Approval For Shingles Vaccine In Adults Over 18 Years
08:00GSK plc Announces the Submission of A Regulatory Application to the Japanese Ministry o..
06:34GSK Submits Shingrix Regulatory Application in Japan for Adults 18 and Older
27/06GSK's Haleon Selects Citigroup, UBS Group of Planned Spinoff on London Bourse
27/06GSK Says Antiviral Drug Lowered Hepatitis B Surface Antigen in Phase 2b Trial
27/06GSK presents promising new data for bepirovirsen, an investigational treatment for chro..
27/06GSK's Investigational Hepatitis B Drug Shows Potential as Functional Cure in Phase 2b S..
26/06CORONA-BLOG/Biontech meldet wirksamen Impfstoff gegen Omikron-Varianten BA.4 und BA.5
25/06GSK : presents promising new data for bepirovirsen, an investigational treatment for chron..
25/06Promising hep B data helps GSK inch closer to functional cure
24/06European Stocks Join Global Rally, Closes Week in the Green
24/06MÄRKTE EUROPA/Börsen gehen deutlich fester ins Wochenende
24/06MÄRKTE EUROPA/Börsen bleiben gut unterstützt
24/06SECTOR UPDATE : Health Care Stocks Edge Higher Premarket Friday
24/06Sanofi-GSK legen Ergebnisse zu Impfstoff-Studie unter Omikron vor
24/06GSK : données positives pour le vaccin Covid-19 Bêta
24/06CAC40 : un rebond se dessine, porté par la détente des taux
24/06European shares mark strong end to nervous week
24/06Sanofi, GSK variant-specific COVID shot found effective against Omicron
24/06Sanofi, GSK COVID-19 Bivalent Vaccine Candidate Shows 72% Efficacy Against Omicron in P..
24/06Sanofi annonce le succès de la 1ère étude d'efficacité de son candidat vaccin contre Om..
24/06Sanofi, GSK Target COVID-19 Vaccine Availability in Late-2022 After New Positive Late-s..
24/06Deux à la douzaine
24/06Les valeurs à suivre aujourd'hui à la Bourse de Paris - Vendredi 24 juin 2022
24/06Sanofi annonce le succès de la 1ère étude d’efficacité de son candidat vaccin contre Om..
24/06SANOFI : succès de la première étude d’efficacité du vaccin Covid-19 Bêta contre Omicron
24/06SANOFI : données positives pour le vaccin Covid-19 Bêta
24/06Le CAC 40 est attendu en hausse après la clôture dans le vert de Wall Street
24/06Sanofi-GSK's COVID-19 Jab 72% Effective Against Omicron Variant in Late-stage Study
24/06EN DIRECT DES MARCHES : Stellantis, Sanofi, Capgemini, GTT, Fedex, Zalando, Mercedes, Atla..
24/06CORONA-BLOG/Sanofi und GSK mit erfolgreicher Impfstoff-Studie gegen Omikron
24/06Le vaccin de Sanofi et GSK avec l'antigène Bêta démontre son efficacité contre Omicron
24/06Sanofi says COVID-19 vaccine candidate yields positive trial data
24/06GSK : Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19..
24/06GSK Says Sanofi-GSK First To Report Successful Efficacy Study Against Omicron With COVI..
24/06Sanofi, GSK Report Successful Vaccine Study Against Omicron
23/06Oragenics Appoints Kimberly Murphy as President, CEO
23/06GSK Announces £1 Billion R&D Investment over Ten Years to Get Ahead of Infectious Disea..
23/06GSK : investissement de 1 Md£ en 10 ans dans la R&D
23/06GSK to Invest $1.22 Billion in Infectious Disease Research for Lower-Income Countries
23/06GSK bekämpft mit 1 Mrd Pfund Infektionskrankheiten in armen Ländern
23/06GSK to Invest GBP1 Billion Tackling Infectious Diseases in Low-Income Countries
23/06Viridian Therapeutics Appoints Carrie Melvin to Fill New COO Role
23/06GSK Unveils $1.22 Billion R&D Investment Plan for Infectious Diseases
23/06Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer
23/06GSK Announces £1 Billion Research And Development Investment
23/06GSK : announces £1 billion R&D investment over ten years to get ahead of infectious diseas..
23/06GSK, Novartis pledge funds for diseases that mostly affect the poor
23/06Fitch Maintains, Withdraws GSK Ratings for Commercial Reasons
16/06GSK : 'offre une valeur attrayante' selon Jefferies
16/06GSK Spinoff Haleon to Debut in London on July 18, FTSE Russell Confirms
15/06FTSE Russell Says Haleon Will Be Added To All Same Indices As GSK On July 18
15/06GSK to Present New Data from the B-Clear Phase IIb Trial for Bepirovirsen in Chronic He..
15/06GSK : to present new data from the B-Clear phase IIb trial for bepirovirsen in chronic hep..
15/06SOLOCAL : nomination d'un directeur des ressources humaines
14/06TRANSCRIPT : GSK plc Presents at 19th annual dbAccess Global Consumer Conference 2022, Jun..
14/06FTSE 100 falls for six straight sessions on rising rate-hike bets
13/06TRANSCRIPT : GSK plc Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, J..
13/06CORONA-BLOG/FDA : Biontech -Impfstoff bei Unter-Fünfjährigen sicher und wirksam
13/06CORONA-BLOG/Booster-Impfung von Sanofi und GSK soll auch gegen Omikron schützen
13/06GSK : UBS réitère son objectif après un essai clinique
13/06Sanofi, GSK COVID-19 Booster Injection Shows Strong Immune Response Against Omicron, Ot..
13/06Sanofi says next-gen COVID booster shot has potential against main variants
13/06Sanofi-GSK Says COVID-19 Booster Provides Stronger Protection Against Omicron, Other Va..
13/06CORRECTION : Sanofi-GSK COVID-19 Booster Jab Shows Strong Immune Response Against Multiple..
13/06Forte réponse immunitaire du vaccin de Sanofi contre le COVID-19
13/06Les valeurs à suivre aujourd'hui à la Bourse de Paris - Lundi 13 juin 2022
13/06Un bon coup derrière la tête
13/06CORONA-BLOG/SANOFI-GSK : Covid-19 Booster zeigt starke Immunreaktion
13/06SANOFI : le vaccin de rappel induit une forte réponse immunitaire contre les variants préo..
13/06EN DIRECT DES MARCHES : TotalEnergies, Thales, Atos, Orpea, Hopium, Crédit Suisse, Goldman..
13/06Coronabooster GSK en Sanofi levert sterke immuunrespons op
1  2  3  4  5  6  7  8  9  10Siguiente
Próximo evento sobre GSK PLC